L364-0030 Screening compound: 4-[5-(3,4-dimethoxybenzenesulfonamido)-1-methyl-1H-1,3-benzodiazol-2-yl]-N-ethylbenzamide

L364-0030 Screening compound: 4-[5-(3,4-dimethoxybenzenesulfonamido)-1-methyl-1H-1,3-benzodiazol-2-yl]-N-ethylbenzamide
L364-0030 Screening compound: 4-[5-(3,4-dimethoxybenzenesulfonamido)-1-methyl-1H-1,3-benzodiazol-2-yl]-N-ethylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L364-0030
4-[5-(3,4-dimethoxybenzenesulfonamido)-1-methyl-1H-1,3-benzodiazol-2-yl]-N-ethylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L364-0030

Molecular Formula

C25H26N4O5S (C25 H26 N4 O5 S)

Compound Name

4-[5-(3,4-dimethoxybenzenesulfonamido)-1-methyl-1H-1,3-benzodiazol-2-yl]-N-ethylbenzamide

IUPAC name

4-[5-(34-dimethoxybenzenesulfonamido)-1-methyl-1H-13-benzodiazol-2-yl]-N-ethylbenzamide

SMILES

CCNC(c(cc1)ccc1-c1nc(cc(cc2)NS(c(cc3)cc(OC)c3OC)(=O)=O)c2n1C)=O

InChI

InChI=1S/C25H26N4O5S/c1-5-26-25(30)17-8-6-16(7-9-17)24-27-20-14-18(10-12-21(20)29(24)2)28-35(31,32)19-11-13-22(33-3)23(15-19)34-4/h6-15,28H,5H2,1-4H3,(H,26,30)

InChI Key

IXMFJAMNFLSFRB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27247812

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.251

Distribution Coefficient, logD

3.247

Water Solubility, LogSw

-3.72

Polar Surface Area

91.198

Acid Dissociation Constant (pKa)

10.01

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

L364-0030 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with L364-0030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L364-0030?
Check Price and Availability of L364-0030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L364-0030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L364-0030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L364-0030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L364-0030 available by request